Shockwave Medical to Present at the Canaccord Genuity 40th Annual Growth Conference
Get Alerts SWAV Hot Sheet
Join SI Premium – FREE
SANTA CLARA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that it will be participating in the Canaccord Genuity 40th Annual Growth Conference, scheduled to be held virtually August 11 to 13, 2020.
Shockwave's management is scheduled for a live fireside chat on Wednesday, August 12, 2020, at 2:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the event on the "Investors" section of the company’s website at https://ir.shockwavemedical.com.
About Shockwave Medical, Inc.
Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.
Media Contact: Scott Shadiow +1.317.432.9210[email protected]
Investor Contact:Debbie Kaster[email protected]
Source: Shockwave Medical, Inc.Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: GameStop falls; Merck, Robinhood and Moderna rise
- Jacobio Pharma Announces 2023 Annual Results
- CL King Starts Shockwave Medical (SWAV) at Buy
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!